pros and cons of glp-1 Comparing GLP‑1 Drugs With Other Weight Loss Methods: Diet & Exercise, Bariatric Surgery, Lifestyle Programs -Pros & Should Employers Cover GLP-1s in

These medications have demonstrated significant weight loss (5-22%) and metabolic benefits in rigorous clinical trials when prescribed and monitored by healthcare providers

Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment

For this reason, experts advocate using only supervised clinical settings with greater regulation as a means of protecting patients

Some researchers have hypothesized that GLP-1 receptor stimulation might promote pancreatic duct cell proliferation or increase pancreatic enzyme secretion, but animal studies have not consistently demonstrated these effects at therapeutic doses